ATE425167T1 - Neue pyridothienopyrimidinderivate - Google Patents

Neue pyridothienopyrimidinderivate

Info

Publication number
ATE425167T1
ATE425167T1 AT05814833T AT05814833T ATE425167T1 AT E425167 T1 ATE425167 T1 AT E425167T1 AT 05814833 T AT05814833 T AT 05814833T AT 05814833 T AT05814833 T AT 05814833T AT E425167 T1 ATE425167 T1 AT E425167T1
Authority
AT
Austria
Prior art keywords
pyridothienopyrimide
derivatives
new
pyridothienopyrimide derivatives
new pyridothienopyrimide
Prior art date
Application number
AT05814833T
Other languages
English (en)
Inventor
Santacana Lluis Pages
Moll Joan Taltavull
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Lab filed Critical Almirall Lab
Application granted granted Critical
Publication of ATE425167T1 publication Critical patent/ATE425167T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05814833T 2004-11-30 2005-11-30 Neue pyridothienopyrimidinderivate ATE425167T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200402876A ES2259891B1 (es) 2004-11-30 2004-11-30 Nuevos derivados de piridotienopirimidina.

Publications (1)

Publication Number Publication Date
ATE425167T1 true ATE425167T1 (de) 2009-03-15

Family

ID=35064879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05814833T ATE425167T1 (de) 2004-11-30 2005-11-30 Neue pyridothienopyrimidinderivate

Country Status (21)

Country Link
US (1) US20090029955A1 (de)
EP (1) EP1819710B1 (de)
JP (1) JP2008521855A (de)
KR (1) KR20070086869A (de)
CN (1) CN101068816A (de)
AR (1) AR051686A1 (de)
AT (1) ATE425167T1 (de)
AU (1) AU2005311423A1 (de)
BR (1) BRPI0518094A (de)
CA (1) CA2588741A1 (de)
DE (1) DE602005013278D1 (de)
ES (2) ES2259891B1 (de)
IL (1) IL183142A0 (de)
MX (1) MX2007006173A (de)
NO (1) NO20073283L (de)
PE (1) PE20061078A1 (de)
RU (1) RU2007124326A (de)
TW (1) TW200635932A (de)
UY (1) UY29239A1 (de)
WO (1) WO2006058724A1 (de)
ZA (1) ZA200703827B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
ES2281251B1 (es) * 2005-07-27 2008-08-16 Laboratorios Almirall S.A. Nuevos derivados de pirido (3',2':4,5) furo (3,2-d) pirimidina.
CA2623026A1 (en) * 2005-09-23 2007-04-05 Schering Corporation Fused tetracyclic mglur1 antagonists as therapeutic agents
CN103003284B (zh) * 2010-04-14 2016-01-20 拜耳知识产权有限责任公司 制备二噻烯-四甲酰亚胺的方法
GEP20207167B (en) 2016-06-22 2020-10-12 Univ Vanderbilt Positive allosteric modulators of the muscarinic acetylcholine receptor m4
US10961253B2 (en) 2016-11-07 2021-03-30 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
CN109863139B (zh) 2016-11-07 2023-02-17 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
JP7098167B2 (ja) 2016-11-07 2022-07-11 ヴァンダービルト ユニヴァーシティ ムスカリン性アセチルコリンレセプターｍ４のポジティブアロステリック調節因子
TW201930311A (zh) 2017-12-05 2019-08-01 泛德比爾特大學 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑
US11376254B2 (en) 2017-12-05 2022-07-05 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
IL292515A (en) * 2019-11-13 2022-06-01 Metabomed Ltd Glucose uptake inhibitors and uses thereof
CN115684415B (zh) * 2022-11-02 2024-09-10 山东华泰新材料技术研发有限公司 一种高效液相色谱测定5,6-二氢环戊并[b]噻吩-4-酮含量的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
EP1167367A4 (de) * 1999-03-30 2002-04-24 Nippon Soda Co Thienopyrimidin-verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES2259891A1 (es) 2006-10-16
WO2006058724A1 (en) 2006-06-08
PE20061078A1 (es) 2006-11-10
EP1819710B1 (de) 2009-03-11
KR20070086869A (ko) 2007-08-27
AR051686A1 (es) 2007-01-31
JP2008521855A (ja) 2008-06-26
CN101068816A (zh) 2007-11-07
ES2259891B1 (es) 2007-11-01
DE602005013278D1 (de) 2009-04-23
UY29239A1 (es) 2006-02-24
MX2007006173A (es) 2007-07-09
ES2321966T3 (es) 2009-06-15
US20090029955A1 (en) 2009-01-29
AU2005311423A1 (en) 2006-06-08
HK1101638A1 (en) 2007-10-18
TW200635932A (en) 2006-10-16
RU2007124326A (ru) 2009-01-10
CA2588741A1 (en) 2006-06-08
ZA200703827B (en) 2008-08-27
IL183142A0 (en) 2007-09-20
EP1819710A1 (de) 2007-08-22
NO20073283L (no) 2007-06-27
BRPI0518094A (pt) 2008-10-28

Similar Documents

Publication Publication Date Title
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
ATE394399T1 (de) Tetrahydropyridoindolderivate
EP1756259A4 (de) Rührkesselreaktorsystem
DE602005016654D1 (de) Ltungssystem
ATE540935T1 (de) Chinazolinderivate
DE602004029102D1 (de) Spiegelwinkeleinstellvorrichtung
DK1761541T3 (da) Pyrrazolo-pyrimidin-derivater
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
DE602005013397D1 (de) Radom-struktur
ATE417830T1 (de) Sulfonylbenzimidazolderivate
ATE387440T1 (de) Neue 4-benzylidenpiperidinderivate
ATE392425T1 (de) Thiazolyl-dihydro-indazole
EP1839669A4 (de) Neue angiogenesehemmer
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
DE602005023145D1 (de) Neue androgene
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
DE502005008587D1 (de) Kugelgelenk
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
DK1740574T3 (da) 4-amino-5-cyanopyrimidinderivater
DE602005008596D1 (de) Neue tetracyclische tetrahydrofuranderivate
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
AT500198B8 (de) Ladewagen
DE602005010598D1 (de) Acrylsolzusammensetzung
DE602005020949D1 (de) Elastomerpolyolefinzusammensetzungen
DE602004013423D1 (de) Kraftstoffverteilerkomponent

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties